Work Ability in Young Adult Cancer Survivors

  • STATUS
    Recruiting
  • days left to enroll
    35
  • participants needed
    220
  • sponsor
    Wake Forest University Health Sciences
Updated on 30 September 2020
Investigator
Karen Craver
Primary Contact
Kaiser Permanente-Walnut Creek (0.7 mi away) Contact
+271 other location

Summary

To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.

Description

This observational, cross-sectional study will recruit 220 analyzable YA survivors through the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base (WF NCORP RB). Data will be collected using a web-based interface and will capture physical, psychosocial and cognitive late effects; work ability; work-related outcomes, including labor force participation, occupation, work place characteristics, and educational attainment; survivor characteristics; and cancer diagnosis/treatment information (from clinical records). We will evaluate the relationships among these measures using the theoretical framework to guide statistical analysis.

Details
Treatment questionnaire administration, cognitive assessment, Data Collection Only:
Clinical Study IdentifierNCT03148080
SponsorWake Forest University Health Sciences
Last Modified on30 September 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 25 yrs and 34 yrs?
Gender: Male or Female
Do you have any of these conditions: Cancer Survivors or Cancer Survivor?
>= 2 to < 10 years post-cancer diagnosis (per diagnostic pathology report)
Diagnosed with first cancer (any type except types listed in exclusion criteria below) at age >= 15 years
Ability to understand and willingness to sign a written informed consent document
Must be able to read and understand English

Exclusion Criteria

Currently receiving active cancer treatment (acceptable to be on maintenance or hormonal therapies)
Life expectancy less than 6 months
Precancerous or pre invasive conditions (myelodysplastic syndrome; carcinoma in situ; non-melanoma skin cancer) without progression to malignancy without another prior primary cancer diagnosis; (those who have had these conditions may participate IF they have a primary cancer diagnosis)
Non-Hispanic Whites (effective 11/01/2018)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet